The collaboration expands access to pathology-based biomarker testing, helping accelerate neurodegenerative disease research and therapeutic development across Europe. "The demand for seed amplification testing from European researchers and biopharma sponsors is already strong. The collaboration strengthens Amprion's growing international network of biopharma partnerships and expands access to a-synuclein seed amplification testing for multicenter clinical trials across Europe. Together with Amprion's expanding manufacturing capabilities, the agreement supports the company's broader strategy to advance biomarker-driven neurodegenerative disease research worldwide. About MLM Medical LabsMLM Medical Labs is a global central and specialty laboratory providing comprehensive support for clinical trials across all phases of drug development.